The ACDC is an extremely powerful, secure, and user-friendly platform for discovery and validation of markers of early atherosclerosis and cardiovascular disease risk.
It will bring together up to 19 well-phenotyped cohorts involving 394,000 individuals, with molecular profiling (genomic, metabolomic, lipidomic, proteomic, etc.) of 70,000.